Miral Dental Clinics Co. (9604) fair value: what the stock is really worth
We calculate from audited financials what Miral Dental Clinics Co. is really worth. The fair value tells you whether the price is too high or too low, the quality score (0 to 100) how solid the business behind it is. 26 models, 37 quality factors, updated daily.
Watch Miral Dental Clinics Co. for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for free
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 13, 2026.
How to read this chart
28‑month range 70.26 SAR – 131.56 SAR · fair‑value band 98.35 SAR – 202.00 SAR · the 99.60 SAR price screens below the 157.64 SAR fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 13, 2026.
Miral Dental Company provides dental services in Saudi Arabia. The company is based in Riyadh, Saudi Arabia.
Stock analysis
Miral Dental Clinics Co. (9604) currently trades at 99.60 SAR, while our model-based Fair Value estimate is 157.64 SAR, implying the stock looks roughly 36.8% undervalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of 180.32 SAR per share, and 20 of the 24 models we run sit above the 99.60 SAR price.
Bear case: the Asset-Based group reads lowest at 26.05 SAR, and 4 of the 24 models stay below the price. Evidence for this calculation is low.
Scenario range: 98.35 SAR (bear) to 202.00 SAR (bull), the price of 99.60 SAR sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 64/100 (solid quality), in the Healthcare sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Miral Dental Clinics Co. reported revenue of 83.0M SAR in FY2025 versus 58.5M SAR in FY2022, a compound +12.4%/yr. Reported net income was 18.4M SAR in FY2025, compounding +17.8%/yr from FY2022.
Key figures
Market cap 199M SAR (≈ $53.1M) · P/E ratio 10.8 · P/S ratio 2.40 · EPS (TTM) 9.19 SAR · Net margin 22.1% · Return on assets (EBIT) 23.7% · Free cash flow 17.9M SAR · Net cash 2.2M SAR.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 55 out of 100 (medium confidence).
What moves the price
The share trades about 17% below its 52-week high and 6% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 0% fair-value upside, at 58%, 9604 screens cheaper than that median.
Fair Value models
Bear 98.35 SARFair Value 157.64 SARBull 202.00 SAR
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 8 months old). Earnings retained since then (6.50 SAR per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.87/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+11.5%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+12.4%
’22
’23
’24
’25
What shareholders gained per year (last 3 years) (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 3 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip.
+19.8%
Earnings growth per share plus dividend.
Earnings per share, growth per year+19.8%
Dividend (yield on the price)0.0%
Profit margin 2022 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.22% → 23%
2025 sits 54% above its own trend. The rate follows the median trend of the last 3 years, not that single year.
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−1.2%
Yearly growth needed for the next five years to justify today's price.
Compare Miral Dental Clinics Co. with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 257 stocks
Beats the industry median on 6/11 measures
A mixed picture versus its industry peers.
Valuation
Quality Score64 · Top 25%
Fair Value upside+59% · Top 25%
Profitability
Return on assets0% · Bottom 25%
Net margin (TTM)0% · Bottom 25%
Operating margin (TTM)0% · Bottom 25%
Growth and dividend
Revenue growth0% · Below median
Dividend yield (TTM)0.0% · Bottom 25%
Valuation Multiplesvs Medical Care Facilities median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Miral Dental Clinics Co. (9604) overvalued or undervalued?
As of Sep 13, 2026, our model estimates a fair value of 157.64 SAR versus a price of 99.60 SAR, about +58% upside (undervalued).
What is the fair value of 9604?
Our model-based fair value for Miral Dental Clinics Co. is 157.64 SAR (as of Sep 13, 2026), built from audited fundamentals. The current price: 99.60 SAR.
What is the quality score of 9604?
Miral Dental Clinics Co. has a Quality Score of 64/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Miral Dental Clinics Co. (9604)?
Our model-based price target is the fair value of 157.64 SAR (as of Sep 13, 2026) from 24 valuation models. Cautious scenario 98.35 SAR, optimistic scenario 202.00 SAR. It is a calculation from audited fundamentals, not an analyst target.
What is the Miral Dental Clinics Co. stock forecast for 2026?
Our models put fair value at 157.64 SAR, about +58% upside versus a price of 99.60 SAR (undervalued). Cautious scenario 98.35 SAR, optimistic scenario 202.00 SAR. The calculation is refreshed regularly with new filings.
What growth is priced into Miral Dental Clinics Co. (9604)?
For today's price to be fair in a discounted-cash-flow model, Miral Dental Clinics Co. would have to grow free cash flow by -1.2 % per year for five years (discount rate 13.3 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 3 years revenue grew +12.4 % per year. As of Sep 13, 2026.
What discount rate (WACC) does the fair value of 9604 use?
Our models discount Miral Dental Clinics Co. at 13.3 %: a base by market capitalisation (micro), country premium for Saudi Arabia. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Miral Dental Clinics Co. that is -1.2 % per year a year over ten years, using the same discount rate (13.3 %) and the same formula as our fair value.
How much growth has Miral Dental Clinics Co. (9604) delivered so far?
Over the past 3 years revenue at Miral Dental Clinics Co. grew +12.4 % a year. The price currently implies -1.2 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Miral Dental Clinics Co. (9604) growing?
The median revenue growth in the sector is +0.0 % a year. That is the yardstick for the growth priced into Miral Dental Clinics Co. (-1.2 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Miral Dental Clinics Co. (9604)?
The free-cash-flow yield on the price is 8.98 %: that much free cash flow Miral Dental Clinics Co. produces per unit of market value. When it exceeds the discount rate of our models (13.3 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Miral Dental Clinics Co. (9604)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Miral Dental Clinics Co. it is 157.64 SAR per share (as of Sep 13, 2026), against a price of 99.60 SAR. It is the blended result of 24 valuation models (cash flow, earnings, asset, dividend).
Is Miral Dental Clinics Co. stock overvalued or undervalued in 2026?
As of Sep 13, 2026, 9604 trades below its calculated fair value: price 99.60 SAR, fair value 157.64 SAR, a gap of about +58% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 9604?
No. The price is what the market pays today (99.60 SAR); the fair value is what the company's own numbers justify (157.64 SAR). For Miral Dental Clinics Co. the two are 58.04 SAR per share apart. That gap is exactly why we show both numbers side by side.
How much is Miral Dental Clinics Co. worth?
The market values Miral Dental Clinics Co. at about 199M SAR (market capitalisation, as of Sep 13, 2026). Per share that is 99.60 SAR; our models calculate a fair value of 157.64 SAR per share.
What do the bullish and bearish scenarios say about 9604?
Our models span a range for Miral Dental Clinics Co.: cautious scenario 98.35 SAR, base 157.64 SAR, optimistic 202.00 SAR per share (as of Sep 13, 2026, price 99.60 SAR). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 9604?
Miral Dental Clinics Co. trades at a price-to-earnings ratio of 10.8 (as of Sep 13, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 157.64 SAR is built from several models across several years. Other multiples: P/B 0.7, EV/EBITDA 1.9.
How far is 9604 from its 52-week high?
Miral Dental Clinics Co. trades at 99.60 SAR, about 17% below its 52-week high of 120.69 SAR and 6% above the low of 93.89 SAR (as of Sep 13, 2026). Distance from the high says nothing about value: that is what the fair value of 157.64 SAR is for.
Which stocks are comparable to Miral Dental Clinics Co.?
From the same area (Healthcare) we also value HCA Healthcare, Inc, Fresenius SE, Dr. Sulaiman Al Habib Medical Services Group, IHH Healthcare Berhad, an investment holding company,, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Miral Dental Clinics Co. stock attractive at the current price?
The data as of Sep 13, 2026: price 99.60 SAR, calculated fair value 157.64 SAR (+58%), Quality Score 64/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 9604 calculated?
We run Miral Dental Clinics Co. through 24 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 157.64 SAR, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.6 % above its aggregate fair value. Miral Dental Clinics Co. currently trades 58 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Miral Dental Clinics Co. (9604)?
The closing price on Sep 14, 2026 was 99.60 SAR. Our model-based fair value is 157.64 SAR, about +58% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Miral Dental Clinics Co. right now?
The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid quality (64/100) at a price below fair value, the discount is the argument here, not the business quality. A fairly wide model range (98.35 SAR to 202.00 SAR) leaves room in how you read the outcome.
Key figures of Miral Dental Clinics Co.
How large is the market capitalisation of Miral Dental Clinics Co. (9604)?
The market capitalisation of Miral Dental Clinics Co. is 199M SAR (≈ $53.1M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Miral Dental Clinics Co. (9604)?
The price-to-sales ratio of Miral Dental Clinics Co. is 2.40 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Miral Dental Clinics Co. (9604)?
Earnings per share at Miral Dental Clinics Co. are 9.19 SAR (price ÷ EPS = P/E 10.8). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Miral Dental Clinics Co. (9604)?
The net margin of Miral Dental Clinics Co. is 22.1% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the EBIT return on assets of Miral Dental Clinics Co. (9604)?
On an EBIT basis the return on assets of Miral Dental Clinics Co. is 23.7% (avg 4y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
How much net cash does Miral Dental Clinics Co. (9604) hold?
Miral Dental Clinics Co. holds more cash than debt, 2.2M SAR net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Miral Dental Clinics Co. in the live analysis
One click puts Miral Dental Clinics Co. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
